EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Bone Tissue Engineering: Enhancing the Potential of Mesenchymal Stem Cells for Regenerative Therapies

Milena Kostadinova iD, Miryana Raykovska iD, Radoil Simeonov iD, Stephan Lolov iD, Milena Mourdjeva iD

Current Issues in Molecular Biology · 17.04.2025 · 47 (4) · 287

DOI: 10.3390/cimb47040287 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 17.04.2025. Verfasst von Milena Kostadinova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biology and Immunology of Reproduction, Department of Molecular Immunology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FNI-Bulgaria; InfraACT, FNI-Bulgaria, InfraACT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone tissue engineering (BTE) has emerged as a promising strategy for addressing bone defects and disorders that cannot be repaired through traditional methods. This field leverages the potential of various biomaterials, cells, and bioactive factors to promote bone regeneration. Mesenchymal stem cells (MSCs) have gained significant attention due to their osteogenic potential, which can be enhanced through osteoinductive factors. Osteoinductive factors, including growth factors like BMPs, TGF-β, VEGF, and IGF, play a crucial role in stimulating the osteodifferentiation process, thereby promoting bone regeneration. Furthermore, bioprinting technologies have opened new avenues for precisely designing scaffolds that can mimic the native bone architecture and provide a conducive environment for MSC differentiation. The integration of bioprinting with mesenchymal stem cells and osteoinductive factors has the potential to revolutionize regenerative therapies by allowing for the creation of patient-specific bone grafts. This review highlights the latest developments in MSC-based therapies, the role of osteoinductive factors, and the impact of bioprinting in advancing BTE. It also discusses future directions for improving the efficacy and clinical translation of these technologies.

Schlagwörter

Stichwörter der Autor:innen

bioprintingbone tissue engineeringcritical-size bone defectsmesenchymal stem cellsosteogenic differentiationosteoinductive factors

Autor:innen und Institutionen

  • Institute of Biology and Immunology of Reproduction, Department of Molecular Immunology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
  • Institute of Information and Communication Technologies, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
  • Department of Orthopedics and Traumatology, University Hospital Queen Giovanna-ISUL, 1527 Sofia, Bulgaria.

ORCID-Profile: Milena Kostadinova, Miryana Raykovska, Radoil Simeonov, Stephan Lolov, Milena Mourdjeva

Förderung

  • FNI-Bulgaria; InfraACT
  • FNI-Bulgaria
  • InfraACT
  • National Roadmap

Zitieren

APA

Kostadinova, M., Raykovska, M., Simeonov, R., Lolov, S., & Mourdjeva, M. (2025). Recent Advances in Bone Tissue Engineering: Enhancing the Potential of Mesenchymal Stem Cells for Regenerative Therapies. Current Issues in Molecular Biology, 47(4), 287. https://doi.org/10.3390/cimb47040287

Vancouver

Kostadinova M, Raykovska M, Simeonov R, Lolov S, Mourdjeva M. Recent Advances in Bone Tissue Engineering: Enhancing the Potential of Mesenchymal Stem Cells for Regenerative Therapies. Current Issues in Molecular Biology. 2025;47(4):287. doi:10.3390/cimb47040287

BibTeX
@article{Kostadinova2025,
  author = {Kostadinova, Milena and Raykovska, Miryana and Simeonov, Radoil and Lolov, Stephan and Mourdjeva, Milena},
  title = {Recent Advances in Bone Tissue Engineering: Enhancing the Potential of Mesenchymal Stem Cells for Regenerative Therapies},
  journal = {Current Issues in Molecular Biology},
  year = {2025},
  volume = {47},
  number = {4},
  pages = {287},
  doi = {10.3390/cimb47040287}
}
Kostenlos starten →